Using multiplex flow cytometry, we demonstrate that synergistic treatment increased populations of CD8+, CD4+ tumor infiltrating lymphocytes and a shift from monocytic myeloid-derived suppressor cells (mMDSC) to granulocytic myeloid derived suppressor cells (gMDSC). The gene discussed is CD4; the disease is neoplasm.